ATYR Q4 2019 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$144,000

Gross Profit

$144,000100.0% margin

Operating Income

-$6M-4140.3% margin

Net Income

-$6M-4147.9% margin

EPS (Diluted)

$-1.54

QoQ Revenue Growth

-21.7%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$425,000

Balance Sheet

Total Assets

$36M

Total Liabilities

$15M

Stockholders' Equity

$21M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$144,000	$0	—
Gross Profit	$144,000	$0	—
Operating Income	-$6M	-$6M	+0.0%
Net Income	-$6M	-$6M	+5.5%